Management of Egfr-Mutated Non-Small-Cell Lung Cancer: Practical Implications from a Clinical and Pathology Perspective
Abstract
Share and Cite
Cabanero, M.; Sangha, R.; Sheffield, B.S.; Sukhai, M.; Pakkal, M.; Kamel-Reid, S.; Karsan, A.; Ionescu, D.; Juergens, R.A.; Butts, C.; et al. Management of Egfr-Mutated Non-Small-Cell Lung Cancer: Practical Implications from a Clinical and Pathology Perspective. Curr. Oncol. 2017, 24, 111-119. https://doi.org/10.3747/co.24.3524
Cabanero M, Sangha R, Sheffield BS, Sukhai M, Pakkal M, Kamel-Reid S, Karsan A, Ionescu D, Juergens RA, Butts C, et al. Management of Egfr-Mutated Non-Small-Cell Lung Cancer: Practical Implications from a Clinical and Pathology Perspective. Current Oncology. 2017; 24(2):111-119. https://doi.org/10.3747/co.24.3524
Chicago/Turabian StyleCabanero, M., R. Sangha, B.S. Sheffield, M. Sukhai, M. Pakkal, S. Kamel-Reid, A. Karsan, D. Ionescu, R.A. Juergens, C. Butts, and et al. 2017. "Management of Egfr-Mutated Non-Small-Cell Lung Cancer: Practical Implications from a Clinical and Pathology Perspective" Current Oncology 24, no. 2: 111-119. https://doi.org/10.3747/co.24.3524